Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0001415889-25-021130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-05 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $51.74 | -10.7K | 337.8K | -3% | -$555.6K | |
| 2025-08-05 | 2025-08-01 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +75.0K | 348.5K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-05 | S | D | 10,739 | $51.74 | 337,767 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-01 | A | A | 75,000 | $0.00 | 348,506 | D | — | — | (F1) Represents the number of shares of the Issuer's common stock underlying restricted stock units ("RSUs") earned upon the vesting of performance-based restricted stock units ("PSUs") granted in December 2023. On August 1, 2025, the Issuer's board of directors certified the Issuer's achievement of a pre-established regulatory milestone set forth in the PSUs, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 25,000 shares on August 1, 2025 in connection with being earned and are scheduled to vest with respect to the remaining 50,000 shares in equal annual installments on August 1, 2026 and August 1, 2027. (F2) Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025. |